Enhancing User Experience in Virtual Reality Through Optical Flow Simplification with the Help of Physiological Measurements: Pilot Study
Sensors · 16.01.2026 · 26 (2) · 610
DOI: 10.3390/s26020610 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sensors, online erschienen am 16.01.2026. Verfasst von Abdualrhman Abdalhadi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Intelligent Signal and Imaging Research (CISIR), Department of Electrical and Electronics Engineering, Universiti Teknologi PETRONAS (UTP)…. Hauptthemen laut MEDLINE: Virtual Reality, Optic Flow. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universiti Teknologi Petronas, Yayasan UTP, Le Grand Chalon.
Abstract (Originalsprache)
The use of virtual reality (VR) has made significant advancements, and now it is widely used across a range of applications. However, consumers’ capacity to fully enjoy VR experiences continues to be limited by a chronic problem known as cybersickness (CS). This study explores the feasibility of mitigating CS through geometric scene simplification combined with electroencephalography (EEG)-based monitoring. According to the sensory conflict theory, this issue is caused by the discrepancy between the visually induced self-motion (VIMS) through immersive displays and the real motion the vestibular system detects. While prior mitigation strategies have largely relied on hardware modifications or visual field restrictions, this paper introduces a novel framework that integrates geometric scene simplification with EEG-based neurophysiological activity to reduce VIMS during VR immersion. The proposed framework combines EEG neurophysiology, allowing us to monitor users’ brainwave activity and cognitive states during virtual immersion experience. The empirical evidence from our investigation shows a correlation between CS manifestation and neural activation in the parietal and temporal lobes. As an experiment with 15 subjects, statistical differences were significantly different with P= 0.001 and large effect size η2=0.28, while preliminary trends suggest lower neural activation during simplified scenes. Notably, a decrease in neural activation corresponding to reduced optic flow (OF) suggests that VR environment simplification may help attenuate CS symptoms, providing preliminary support for the proposed strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Intelligent Signal and Imaging Research (CISIR), Department of Electrical and Electronics Engineering, Universiti Teknologi PETRONAS (UTP), Seri Iskandar 32610, Malaysia.
- LISPEN, Arts et Métiers Institute of Technology, 71100 Chalon Sur Saone, France.
ORCID-Profile: Abdualrhman Abdalhadi, Ruding Lou, Mohd Zuki Bin Yusoff, Naufal M Saad
Förderung
- Universiti Teknologi Petronas
- Yayasan UTP
- Le Grand Chalon
- the Center for Intelligent Signal and Imaging Research
- Yayasan Universiti Teknologi PETRONAS
Zitieren
APA
Abdalhadi, A., Koundal, N., Moosavi, M. S., Lou, R., Yusoff, M. Z. B., Merienne, F., & Saad, N. M. (2026). Enhancing User Experience in Virtual Reality Through Optical Flow Simplification with the Help of Physiological Measurements: Pilot Study. Sensors, 26(2), 610. https://doi.org/10.3390/s26020610
Vancouver
Abdalhadi A, Koundal N, Moosavi MS, Lou R, Yusoff MZB, Merienne F, et al. Enhancing User Experience in Virtual Reality Through Optical Flow Simplification with the Help of Physiological Measurements: Pilot Study. Sensors. 2026;26(2):610. doi:10.3390/s26020610
BibTeX
@article{Abdalhadi2026,
author = {Abdalhadi, Abdualrhman and Koundal, Nitin and Moosavi, Mahdiyeh Sadat and Lou, Ruding and Yusoff, Mohd Zuki Bin and Merienne, Frédéric and Saad, Naufal M},
title = {Enhancing User Experience in Virtual Reality Through Optical Flow Simplification with the Help of Physiological Measurements: Pilot Study},
journal = {Sensors},
year = {2026},
volume = {26},
number = {2},
pages = {610},
doi = {10.3390/s26020610}
}
EUVIMED